NCT07463677 2026-03-11
Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sun Yat-sen University
Phase 2 Not yet recruiting
Sun Yat-sen University
University of Maryland, Baltimore
Kaohsiung Medical University
National Cancer Centre, Singapore
Tata Memorial Hospital
Jonsson Comprehensive Cancer Center
All India Institute of Medical Sciences
St. Jude Children's Research Hospital